Novel metabolic subtypes in IDH-mutant gliomas: implications for prognosis and therapy
Abstract Background Although IDH-mutant glioma generally has a better prognosis than their IDH-wildtype counterparts, considerable prognostic heterogeneity persists among patients with the same IDH mutation. Current study has primarily focused on the different IDH statuses or grades, while the metab...
Spremljeno u:
| Glavni autori: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2025-04-01
|
| Serija: | BMC Cancer |
| Teme: | |
| Online pristup: | https://doi.org/10.1186/s12885-025-14176-y |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
